Cytomegalovirus proteins. I. Polypeptides of virions and dense bodies. 1976

M Fiala, and R W Honess, and D C Heiner, and J W Heine, and J Murnane, and R Wallace, and L B Guze

Cytomegalovirus virions and dense bodies were purified by sucrose velocity and equilibrium centrifugation from the medium of fibroblasts infected with the strain AD169. The final virus preparations were purified more than 228-fold with respect to cellular proteins as determined by double-isotopic labeling and at least 1,600-fold on the basis of changes in the ratio of total protein to virus particles. The protein content of purified particles approximated that found for purified preparations of other herpesviruses. Twenty polypeptides ranging from 22,000 to greater than 230,000 molecular weight were detected in purified virus preparations by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Polypeptides of virions and dense bodies were allocated on the basis of analyses of preparations containing differing percentages of virions and dense bodies. Six polypeptides were represented predominantly or exclusively in virions, and four polypeptides were represented predominantly or exclusively in dense bodies, whereas the remainder appeared to be shared by both types of particles. Four polypeptides were glycosylated, and at least three of these appeared to be shared by both particles. Four polypeptides were glycosylated, and at least three of these appeared to be shared by both particle types. The protein composition of cytomegalovirus differs profoundly from that of herpes simplex virus.

UI MeSH Term Description Entries
D007181 Inclusion Bodies, Viral An area showing altered staining behavior in the nucleus or cytoplasm of a virus-infected cell. Some inclusion bodies represent "virus factories" in which viral nucleic acid or protein is being synthesized; others are merely artifacts of fixation and staining. One example, Negri bodies, are found in the cytoplasm or processes of nerve cells in animals that have died from rabies. Negri Bodies,Viral Inclusion Bodies,Negri Body,Bodies, Negri,Bodies, Viral Inclusion,Body, Negri,Body, Viral Inclusion,Inclusion Body, Viral,Viral Inclusion Body
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003587 Cytomegalovirus A genus of the family HERPESVIRIDAE, subfamily BETAHERPESVIRINAE, infecting the salivary glands, liver, spleen, lungs, eyes, and other organs, in which they produce characteristically enlarged cells with intranuclear inclusions. Infection with Cytomegalovirus is also seen as an opportunistic infection in AIDS. Herpesvirus 5, Human,Human Herpesvirus 5,Salivary Gland Viruses,HHV 5,Herpesvirus 5 (beta), Human,Cytomegaloviruses,Salivary Gland Virus,Virus, Salivary Gland,Viruses, Salivary Gland
D006023 Glycoproteins Conjugated protein-carbohydrate compounds including MUCINS; mucoid, and AMYLOID glycoproteins. C-Glycosylated Proteins,Glycosylated Protein,Glycosylated Proteins,N-Glycosylated Proteins,O-Glycosylated Proteins,Glycoprotein,Neoglycoproteins,Protein, Glycosylated,Proteins, C-Glycosylated,Proteins, Glycosylated,Proteins, N-Glycosylated,Proteins, O-Glycosylated
D014764 Viral Proteins Proteins found in any species of virus. Gene Products, Viral,Viral Gene Products,Viral Gene Proteins,Viral Protein,Protein, Viral,Proteins, Viral

Related Publications

M Fiala, and R W Honess, and D C Heiner, and J W Heine, and J Murnane, and R Wallace, and L B Guze
August 1977, The Journal of general virology,
M Fiala, and R W Honess, and D C Heiner, and J W Heine, and J Murnane, and R Wallace, and L B Guze
August 1976, Journal of virology,
M Fiala, and R W Honess, and D C Heiner, and J W Heine, and J Murnane, and R Wallace, and L B Guze
January 1994, Research in virology,
M Fiala, and R W Honess, and D C Heiner, and J W Heine, and J Murnane, and R Wallace, and L B Guze
June 2015, Medical microbiology and immunology,
M Fiala, and R W Honess, and D C Heiner, and J W Heine, and J Murnane, and R Wallace, and L B Guze
January 1980, Journal of medical virology,
M Fiala, and R W Honess, and D C Heiner, and J W Heine, and J Murnane, and R Wallace, and L B Guze
May 2017, The Journal of general virology,
M Fiala, and R W Honess, and D C Heiner, and J W Heine, and J Murnane, and R Wallace, and L B Guze
September 1986, Journal of virology,
M Fiala, and R W Honess, and D C Heiner, and J W Heine, and J Murnane, and R Wallace, and L B Guze
March 1982, Journal of virology,
M Fiala, and R W Honess, and D C Heiner, and J W Heine, and J Murnane, and R Wallace, and L B Guze
January 1992, Archives of virology,
M Fiala, and R W Honess, and D C Heiner, and J W Heine, and J Murnane, and R Wallace, and L B Guze
April 1984, Virology,
Copied contents to your clipboard!